You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

China's WuXi Biologics Snaps up Second European Pharma Plant

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 671 Words

GALWAY, IRELAND--December 30, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--China's pharmaceutical major WuXi Biologics has purchased another manufacturing plant in Germany from Bayer stating that it will support its global expansion network for supplying COVID-19 vaccines and other biologics.

Within this article: Details plant purchase, cost, plans, related European plant deals

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00